IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex Threatened with Delisting from NYSE

7:19 AM MDT | April 15, 2009 | Alex Scott

Cambrex, one of the best known U.S. contract fine chemical manufacturers, has disclosed that it has received notification from the New York Stock Exchange (NYSE) that its listing on the exchange is under threat because its market capitalization has dipped below $75 million. NYSE rules stipulate that listed companies must have a market capitalization of more than $75 million over a consecutive 30-day trading period.    Cambrex reported a market capitalization of $74.8 million as of December 31, 2008. The company says that within the next 45...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa